Related Experiment Video

Updated: May 15, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

[Mechanism of action for immunotherapy drugs]

Hideaki Tahara1

  • 1Department of Surgery and Bioengineering, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|December 25, 2012
PubMed

Insights

This review explores diverse reagents for cancer immunotherapy, including innate immunity stimuli, cytokines, vaccines, cellular therapies, gene vectors, and monoclonal antibodies. It details their mechanisms of action in suppressing tumor growth.

Area of Science:

  • Cellular immunology
  • Cancer immunotherapy
  • Tumor biology

Context:

  • Cancer therapy has evolved significantly, leveraging cellular immunity.
  • Diverse reagents are employed, including innate immunity stimulants, cytokines, vaccines, autologous cells, and gene vectors.
  • Monoclonal antibodies represent a recent addition to cancer treatment modalities.

Purpose:

  • To review the characteristics of various cancer immunotherapy reagents.
  • To focus on the mechanisms of action of these therapeutic agents.
  • To highlight the role of basic cellular immunology research in developing these treatments.

Summary:

  • Cancer immunotherapy utilizes reagents like innate immunity stimulants, cytokines, vaccines, cellular therapies, gene vectors, and monoclonal antibodies.
  • These approaches are grounded in fundamental cellular immunology research.
  • The review examines the specific characteristics and action mechanisms of these diverse therapeutic modalities against tumors.

Impact:

  • Provides a comprehensive overview of current cancer immunotherapy reagents.
  • Enhances understanding of how cellular immunity combats cancer.
  • Informs future research and development in cancer treatment strategies.

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Vaccines01:21

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...